Trial
NCT00866476
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
PATH
Condition
Shigella
Intervention
CVD 1208S, a Shigella flexneri 2a live, oral vaccine
Why stopped
Reactogenicity met study halting criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-29